価格表

在庫・価格 : 2024年04月26日 16時55分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
IFN-γ, Canine, ELISpot Kit
データシート※最新のデータシートでない場合があります
EL781 RSDアールアンドディー システムス
R&D Systems, Inc.
1 kit ¥80,000
(未発注)
追加

在庫・価格 : 2024年04月26日 16時55分 現在

IFN-γ, Canine, ELISpot Kit

  • 商品コード:EL781
  • メーカー:RSD
  • 包装:1kit
  • 価格: ¥80,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Mason NJ et al. RNA-loaded CD40-activated B cells stimulate antigen-specific T-cell responses in dogs with spontaneous lymphoma. Gene Ther. 2008 Jul;15(13):955-65
Mason NJ et al
2008/01/01
Species: Canine, Application: Whole Cells PubMed
2 Niemeyer GP et al. Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy. Blood 2009 Jan;113(4):797-806
Niemeyer GP et al
2009/01/01
Sample Type: Whole Cells PubMed
3 Shin JH et al. Microdystrophin ameliorates muscular dystrophy in the canine model of duchenne muscular dystrophy. Mol. Ther. 2013 Apr;21(4):750-7
Shin JH et al
2013/01/01
Sample Type: Cell Culture Supernates PubMed
4 Esch KJ et al. Programmed death 1-mediated T cell exhaustion during visceral leishmaniasis impairs phagocyte function. J. Immunol. 2013 Dec;191(11):5542-50
Esch KJ et al
2013/01/01
Sample Type: Whole Cells PubMed
5 Hartley AN et al. Frequency of IFNγ-producing T cells correlates with seroreactivity and activated T cells during canine Trypanosoma cruzi infection. Vet. Res. 2014;45:6
Hartley AN et al
2014/01/01
Sample Type: Whole Cells PubMed
6 Sun J et al. An Observational Study from Long-Term AAV Re-administration in Two Hemophilia Dogs. Mol Ther Methods Clin Dev 2018 Sep;10:257-267
Sun J et al
2018/01/01
PubMed
7 Budachetri K et al. An Entry-Triggering Protein of <i>Ehrlichia</i> Is a New Vaccine Candidate against Tick-Borne Human Monocytic Ehrlichiosis. mBio 2020 07;11(4)
Budachetri K et al
2020/01/01
Species: Canine PubMed
  • No.: 1
  • 文献情報:
    Mason NJ et al. RNA-loaded CD40-activated B cells stimulate antigen-specific T-cell responses in dogs with spontaneous lymphoma. Gene Ther. 2008 Jul;15(13):955-65
    Mason NJ et al
    2008/01/01
  • 備考:
    Species: Canine, Application: Whole Cells
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Niemeyer GP et al. Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy. Blood 2009 Jan;113(4):797-806
    Niemeyer GP et al
    2009/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Shin JH et al. Microdystrophin ameliorates muscular dystrophy in the canine model of duchenne muscular dystrophy. Mol. Ther. 2013 Apr;21(4):750-7
    Shin JH et al
    2013/01/01
  • 備考:
    Sample Type: Cell Culture Supernates
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Esch KJ et al. Programmed death 1-mediated T cell exhaustion during visceral leishmaniasis impairs phagocyte function. J. Immunol. 2013 Dec;191(11):5542-50
    Esch KJ et al
    2013/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Hartley AN et al. Frequency of IFN&#x3B3;-producing T cells correlates with seroreactivity and activated T cells during canine Trypanosoma cruzi infection. Vet. Res. 2014;45:6
    Hartley AN et al
    2014/01/01
  • 備考:
    Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Sun J et al. An Observational Study from Long-Term AAV Re-administration in Two Hemophilia Dogs. Mol Ther Methods Clin Dev 2018 Sep;10:257-267
    Sun J et al
    2018/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Budachetri K et al. An Entry-Triggering Protein of <i>Ehrlichia</i> Is a New Vaccine Candidate against Tick-Borne Human Monocytic Ehrlichiosis. mBio 2020 07;11(4)
    Budachetri K et al
    2020/01/01
  • 備考:
    Species: Canine
  • 参照:
    PubMed